Molecular modeling and spectroscopic studies on binding of 2,6-bis[4-(4-amino-2-trifluoromethylphenoxy)benzoyl] pyridine to human serum albumin

BAFP (2,6-bis[4-(4-amino-2-trifluoromethylphenoxy)benzoyl] pyridine), a synthesized polyimide compound, was exploited for the first time to analyze its interaction with human serum albumin (HSA) by molecular modeling, fluorescence and Fourier transform infrared attenuated total reflection spectroscopy (FTIR ATR) with drug concentrations of 3.3 × 10⁻⁶ to 3.0 × 10⁻⁵ mol L⁻¹. Molecular docking was performed to reveal the possible binding mode. The results suggested that BAFP can strongly bind to human serum albumin (HSA) and the primary binding site of BAFP is located in site II of HSA, which is supported by the results from the competitive experiment. The binding constants for the interaction of BAFP with HSA have been evaluated from relevant fluorescence data at different temperatures (296, 303, 310 and 308 K). The alterations of the protein secondary structure in the presence of BAFP in aqueous solution were quantitatively calculated by the evidences from FTIR ATR spectroscopes. The binding process was exothermic and spontaneous, as indicated by the thermodynamic analyses, and the major part of the binding energy is hydrophobic interaction, which is also in good agreement with the results of molecule modeling study. The enthalpy change ΔH⁰, the free energy change ΔG⁰ and the entropy change ΔS⁰ of 296 K were calculated to be −7.75, −27.68 kJ mol⁻¹ and 67.33 J mol⁻¹ K⁻¹, respectively.     

应用光谱和分子模拟法研究一种聚酰亚胺聚合物与人免疫球蛋白的相互作用

本文利用荧光猝灭法、红外光谱法及计算机模拟技术研究了一种聚酰亚胺聚合物(2,6-Bis(4-amino-2-trifluoromethyl phenoxy-4’- benzoyl)-pyridine,简称BAFP )与人免疫球蛋白（HIgG）的相互作用。同步荧光的结果定性地说明了BAFP影响水溶液中HIgG二级结构的情况。而判定BAFP影响HIgG二级结构的定量依据来自红外光谱,实验数据表明α螺旋结构的含量相比未加入药物时增加了约2.6～10.2%,,β折叠增大了约13.6～27.7%,,而β转角则减小了约23.8～30.3%。分子模拟的结果显示BAFP与HIgG的键合作用很强,并且有四个氢键在BAFP与HIgG分子的色氨酸Trp 170, 缬氨酸Val 105, 甲硫氨酸Met 139 及天冬酰胺Asn 52之间形成;同时也显示出维持药物与蛋白质的相互作用力主要是疏水作用,这与实验所得到的热力学参数判定作用力的结果相一致（依据范德霍夫公式计算得 与 的值分别为-6.70KJ.mol-1 和 71.93 J.mol-1.K-1）。